The coexpression of SP100 family members with multiple oncogenic genes and their enrichment in various oncogenic pathways provide additional insights into the underlying mechanisms by which the SP100 family members contribute to the initiation and progression of PAAD. This evidence concerns the gene SP100 and pancreatic adenocarcinoma.